Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Cholestasis is a marker for hepatocellular carcinomas displaying beta-catenin mutations.

The Journal of pathology - 1 Jul 2007

Audard V, Grimber G, Elie C, Radenen B, Audebourg A, Letourneur F, Soubrane O, Vacher-Lavenu M-C, Perret C, Cavard C, Terris B

Abstract excerpt

The Wnt/beta-catenin signalling pathway is activated in many human hepatocellular carcinomas (HCC). Identification of beta-catenin mutation relies mostly on sequence analysis and/or immunohistochemistry. beta-catenin mutation may also be detected by analysing the expression of its target genes. T...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to beta Catenin
Share to Carcinoma, Hepatocellular
Share to Chi-Square Distribution

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cholestasis

Share to Glutamate-Ammonia Ligase

Share to Liver Neoplasms

Share to Sensitivity and Specificity

Share to Wnt1 Protein

Source

Identifiers

PMID: 17487939
DOI: 10.1002/path.2169

Genes

GLUL

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-17487939-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Cholestasis is a marker for hepatocellular carcinomas displaying beta-catenin mutations.PMID 17487939Read ↗

Hepatocellular Carcinoma with β-Catenin Mutation: Imaging and Pathologic Characteristics.Semantic proximity Read ↗

Correlation of exon 3 β-catenin mutations with glutamine synthetase staining patterns in hepatocellular adenoma and hepatocellular carcinoma.Semantic proximity Read ↗

Hepatocellular adenomas with high-risk molecular alterations undetected by "high-risk" β-catenin and/or glutamine synthetase staining patterns.Semantic proximity Read ↗

Differential effects of inactivated Axin1 and activated beta-catenin mutations in human hepatocellular carcinomas.Semantic proximity Read ↗

β-Catenin signaling in hepatocellular cancer: Implications in inflammation, fibrosis, and proliferation.Semantic proximity Read ↗

Genotype-phenotype correlation of CTNNB1 mutations reveals different ß-catenin activity associated with liver tumor progression.Semantic proximity Read ↗

Diverse Basis of β-Catenin Activation in Human Hepatocellular Carcinoma: Implications in Biology and Prognosis.Semantic proximity Read ↗

Nuclear localization of beta-catenin is an important prognostic factor in hepatoblastoma.Semantic proximity Read ↗

β-catenin alteration is rare in hepatocellular carcinoma with steatohepatitic features: immunohistochemical and mutational study.Semantic proximity Read ↗

Unique phenotype of hepatocellular cancers with exon-3 mutations in beta-catenin gene.Semantic proximity Read ↗

ALDH3A1 is overexpressed in a subset of hepatocellular carcinoma characterised by activation of the Wnt/ß-catenin pathway.Semantic proximity Read ↗

Hepatocellular adenoma classification: a comparative evaluation of immunohistochemistry and targeted mutational analysis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.